Skip to main content

Table 1 Clinical characteristics of patients with endometrial cancer

From: POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction

Clinical characteristics

Cases (%)

Histological type

 Endometrioid endometrial adenocarcinoma

395(74.81%)

 Mixed serous and endometrioid

22(4.17%)

 Serous endometrial adenocarcinoma

111(21.02%)

Histologic grade

 G1

97(18.37%)

 G2+G3

431(81.63%)

Clinical stage

 I + II

381(72.16%)

 III + IV

147(27.84%)

Age at initial pathologic diagnosis

 < 60

174(32.95%)

 ≥60

352(66.67%)

 NAa

2(0.38%)

Hypertension

 YES

260(49.24%)

 NO

178(33.71%)

 NA

90(17.05%)

History of neo adjuvant treatment

 YES

2(0.38%)

 NO

526(99.26%)

Diabetes

 YES

108(20.45%)

 NO

300(56.82%)

 NA

120(22.73%)

  1. a NA Not available